Your browser doesn't support javascript.
loading
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
Shen, Xiaoying; Basu, Rahul; Sawant, Sheetal; Beaumont, David; Kwa, Sue Fen; LaBranche, Celia; Seaton, Kelly E; Yates, Nicole L; Montefiori, David C; Ferrari, Guido; Wyatt, Linda S; Moss, Bernard; Alam, S Munir; Haynes, Barton F; Tomaras, Georgia D; Robinson, Harriet L.
Afiliación
  • Shen X; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA sxshen@duke.edu hrobinson@geovax.com.
  • Basu R; GeoVax, Inc., Smyrna, Georgia, USA.
  • Sawant S; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Beaumont D; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Kwa SF; GeoVax, Inc., Smyrna, Georgia, USA.
  • LaBranche C; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Seaton KE; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Yates NL; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Ferrari G; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Wyatt LS; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Moss B; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Alam SM; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Haynes BF; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Tomaras GD; Duke Human Vaccine Institute, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Robinson HL; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
J Virol ; 91(24)2017 12 15.
Article en En | MEDLINE | ID: mdl-29021394
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Glicoproteínas / Proteína gp120 de Envoltorio del VIH / Inmunización Secundaria / Vacunas contra el SIDA / Vacunas de ADN / Inmunogenicidad Vacunal Límite: Animals Idioma: En Revista: J Virol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Glicoproteínas / Proteína gp120 de Envoltorio del VIH / Inmunización Secundaria / Vacunas contra el SIDA / Vacunas de ADN / Inmunogenicidad Vacunal Límite: Animals Idioma: En Revista: J Virol Año: 2017 Tipo del documento: Article